Vanguard Asset Management’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.51M Sell
58,460
-5,068
-8% -$143K ﹤0.01% 1695
2026
Q2
$1.96M Buy
63,528
+7,620
+14% +$188K ﹤0.01% 1565
2026
Q1
$1.21M Buy
+55,908
New +$1.21M ﹤0.01% 1703

Other funds holding RCUS

Vanguard Asset Management's RCUS Position: Q3 2026 in Review

Vanguard Asset Management reduced its Arcus Biosciences (RCUS) stake by 8% in Q3 2026, selling an estimated $143K and leaving 58,460 shares worth $1.51M. The position accounts for ﹤0.01% of the portfolio, ranked #1695.

Vanguard Asset Management first reported a position in RCUS in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.96M in Q2 2026. 244 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.

  • Vanguard Asset Management held 58,460 shares of Arcus Biosciences worth $1.51M as of Q3 2026.
  • Vanguard Asset Management sold 5,068 Arcus Biosciences shares in Q3 2026, an estimated $143K.
  • Arcus Biosciences made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #1695 holding.
  • Vanguard Asset Management first reported a position in Arcus Biosciences in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Asset Management's Arcus Biosciences position peaked at $1.96M in Q2 2026.
  • 244 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.

Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.